553 related articles for article (PubMed ID: 21245182)
21. The variable response of women with menopausal hot flashes when treated with sertraline.
Kerwin JP; Gordon PR; Senf JH
Menopause; 2007; 14(5):841-5. PubMed ID: 17413648
[TBL] [Abstract][Full Text] [Related]
22. Ineffectiveness of sertraline for treatment of menopausal hot flushes: a randomized controlled trial.
Grady D; Cohen B; Tice J; Kristof M; Olyaie A; Sawaya GF
Obstet Gynecol; 2007 Apr; 109(4):823-30. PubMed ID: 17400842
[TBL] [Abstract][Full Text] [Related]
23. Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial.
Pinkerton JV; Constantine G; Hwang E; Cheng RF;
Menopause; 2013 Jan; 20(1):28-37. PubMed ID: 23010882
[TBL] [Abstract][Full Text] [Related]
24. SSRIs for hot flashes: a systematic review and meta-analysis of randomized trials.
Shams T; Firwana B; Habib F; Alshahrani A; Alnouh B; Murad MH; Ferwana M
J Gen Intern Med; 2014 Jan; 29(1):204-13. PubMed ID: 23888328
[TBL] [Abstract][Full Text] [Related]
25. Gabapentin for the treatment of menopausal hot flashes: a randomized controlled trial.
Butt DA; Lock M; Lewis JE; Ross S; Moineddin R
Menopause; 2008; 15(2):310-8. PubMed ID: 17917611
[TBL] [Abstract][Full Text] [Related]
26. Sertraline to treat hot flashes: a randomized controlled, double-blind, crossover trial in a general population.
Gordon PR; Kerwin JP; Boesen KG; Senf J
Menopause; 2006; 13(4):568-75. PubMed ID: 16837878
[TBL] [Abstract][Full Text] [Related]
27. Sexual function in nondepressed women using escitalopram for vasomotor symptoms: a randomized controlled trial.
Reed SD; Guthrie KA; Joffe H; Shifren JL; Seguin RA; Freeman EW
Obstet Gynecol; 2012 Mar; 119(3):527-38. PubMed ID: 22353950
[TBL] [Abstract][Full Text] [Related]
28. Effects of a combination of Nigella sativa and Vitex agnus-castus with citalopram on healthy menopausal women with hot flashes: results from a subpopulation analysis.
Molaie M; Darvishi B; Jafari Azar Z; Shirazi M; Amin G; Afshar S
Gynecol Endocrinol; 2019 Jan; 35(1):58-61. PubMed ID: 30129806
[TBL] [Abstract][Full Text] [Related]
29. Clinical hypnosis in the treatment of postmenopausal hot flashes: a randomized controlled trial.
Elkins GR; Fisher WI; Johnson AK; Carpenter JS; Keith TZ
Menopause; 2013 Mar; 20(3):291-8. PubMed ID: 23435026
[TBL] [Abstract][Full Text] [Related]
30. North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes.
Park H; Qin R; Smith TJ; Atherton PJ; Barton DL; Sturtz K; Dakhil SR; Anderson DM; Flynn K; Puttabasavaiah S; Le-Lindqwister NA; Padula GD; Loprinzi CL
Menopause; 2015 Jun; 22(6):627-32. PubMed ID: 25423327
[TBL] [Abstract][Full Text] [Related]
31. Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.
Carpenter JS; Storniolo AM; Johns S; Monahan PO; Azzouz F; Elam JL; Johnson CS; Shelton RC
Oncologist; 2007 Jan; 12(1):124-35. PubMed ID: 17227907
[TBL] [Abstract][Full Text] [Related]
32. Effect of sulpiride on menopausal hot flashes: a randomized, double-blind, placebo-controlled clinical trial.
Borba CM; Ferreira CF; Ferreira FV; Pérez-López FR; Wender MCO
Gynecol Endocrinol; 2020 Mar; 36(3):247-251. PubMed ID: 31476924
[TBL] [Abstract][Full Text] [Related]
33. Pooled Analysis of Six Pharmacologic and Nonpharmacologic Interventions for Vasomotor Symptoms.
Guthrie KA; LaCroix AZ; Ensrud KE; Joffe H; Newton KM; Reed SD; Caan B; Carpenter JS; Cohen LS; Freeman EW; Larson JC; Manson JE; Rexrode K; Skaar TC; Sternfeld B; Anderson GL
Obstet Gynecol; 2015 Aug; 126(2):413-422. PubMed ID: 26241433
[TBL] [Abstract][Full Text] [Related]
34. Evaluation and Comparison of Citalopram and Venlafaxine for Management of Hot Flashes in Women with Breast Cancer.
Taleghani SY; Etesam F; Esfandbod M
Drug Res (Stuttg); 2023 Oct; 73(8):465-472. PubMed ID: 37647930
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial.
Speroff L; Gass M; Constantine G; Olivier S;
Obstet Gynecol; 2008 Jan; 111(1):77-87. PubMed ID: 18165395
[TBL] [Abstract][Full Text] [Related]
36. Phase 3 randomized controlled study of gastroretentive gabapentin for the treatment of moderate-to-severe hot flashes in menopause.
Pinkerton JV; Kagan R; Portman D; Sathyanarayana R; Sweeney M;
Menopause; 2014 Jun; 21(6):567-73. PubMed ID: 24149930
[TBL] [Abstract][Full Text] [Related]
37. Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial.
Stearns V; Slack R; Greep N; Henry-Tilman R; Osborne M; Bunnell C; Ullmer L; Gallagher A; Cullen J; Gehan E; Hayes DF; Isaacs C
J Clin Oncol; 2005 Oct; 23(28):6919-30. PubMed ID: 16192581
[TBL] [Abstract][Full Text] [Related]
38. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
Pelissolo A
Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
[TBL] [Abstract][Full Text] [Related]
39. Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis.
Toulis KA; Tzellos T; Kouvelas D; Goulis DG
Clin Ther; 2009 Feb; 31(2):221-35. PubMed ID: 19302896
[TBL] [Abstract][Full Text] [Related]
40. Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial.
Boekhout AH; Vincent AD; Dalesio OB; van den Bosch J; Foekema-Töns JH; Adriaansz S; Sprangers S; Nuijen B; Beijnen JH; Schellens JH
J Clin Oncol; 2011 Oct; 29(29):3862-8. PubMed ID: 21911720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
